SiBone (SIBN) Financials

$14.60 +0.44 (+3.11%)

Closing price 04:00 PM Eastern

Extended Trading

$14.81 +0.21 (+1.44%)

As of 05:19 PM Eastern

Annual Income Statements for SiBone

This table shows SiBone's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-23	-17	-38	-44	-57	-61	-43	-31	-18
Consolidated Net Income / (Loss)	-23	-17	-38	-44	-57	-61	-43	-31	-19
Net Income / (Loss) Continuing Operations	-23	-17	-38	-44	-57	-61	-43	-31	-19
Total Pre-Tax Income	-23	-17	-38	-44	-57	-61	-43	-31	-19
Total Operating Income	-17	-12	-36	-39	-52	-60	-47	-35	-22
Total Gross Profit	43	51	61	64	80	91	109	132	160
Total Revenue	48	55	67	73	90	106	139	167	201
Operating Revenue	48	55	67	73	90	106	139	167	201
Total Cost of Revenue	5.11	4.83	6.79	8.90	10	16	29	35	41
Operating Cost of Revenue	5.11	4.83	6.79	8.90	10	16	29	35	41
Total Operating Expenses	60	63	97	103	131	150	156	167	182
Selling, General & Admin Expense	13	13	21	20	25	29	31	34	41
Marketing Expense	42	44	68	74	94	108	110	117	124
Research & Development Expense	5.51	5.38	7.28	9.46	12	14	15	17	17
Total Other Income / (Expense), net	-5.69	-5.49	-2.40	-5.13	-4.90	-1.52	3.60	4.34	3.43
Interest Expense	6.20	5.11	4.95	6.10	5.37	2.82	3.46	3.44	2.63
Interest & Investment Income	0.18	0.77	2.55	1.10	0.19	1.30	6.92	7.85	6.07
Other Income / (Expense), net	0.34	-1.15	-0.00	-0.13	0.28	-	0.14	-0.07	-0.02
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	-	-	-	-	-	-	0.06	0.12	-0.56
Basic Earnings per Share	($6.65)	($2.20)	($1.55)	($1.50)	($1.71)	($1.79)	($1.13)	($0.75)	($0.44)
Weighted Average Basic Shares Outstanding	3.47M	7.95M	24.71M	29.06M	33.15M	34.20M	38.43M	41.47M	42.96M
Diluted Earnings per Share	($6.65)	($2.20)	($1.55)	($1.50)	($1.71)	($1.79)	($1.13)	($0.75)	($0.44)
Weighted Average Diluted Shares Outstanding	3.47M	7.95M	24.71M	29.06M	33.15M	34.20M	38.43M	41.47M	42.96M
Weighted Average Basic & Diluted Shares Outstanding	3.47M	7.95M	24.71M	29.06M	33.84M	34.99M	41.06M	42.45M	44.17M
Cash Dividends to Common per Share	$0.00	$0.00	$0.00	$0.00	$0.00	-	-	$0.00	$0.00

This table shows SiBone's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-11	-10	-11	-11	-8.94	-6.58	-4.50	-6.54	-6.15	-4.57	-1.09
Consolidated Net Income / (Loss)	-11	-10	-11	-11	-8.94	-6.58	-4.50	-6.54	-6.15	-4.57	-1.64
Net Income / (Loss) Continuing Operations	-11	-10	-11	-11	-8.94	-6.58	-4.50	-6.54	-6.15	-4.57	-1.64
Total Pre-Tax Income	-11	-10	-11	-11	-8.94	-6.58	-4.42	-6.54	-6.15	-4.54	-1.67
Total Operating Income	-12	-11	-13	-12	-10	-7.63	-5.49	-7.48	-7.00	-5.38	-2.46
Total Gross Profit	27	27	29	30	32	32	39	38	39	39	45
Total Revenue	33	34	39	38	40	40	49	47	49	49	56
Operating Revenue	33	34	39	38	40	40	49	47	49	49	56
Total Cost of Revenue	6.32	7.04	10	8.00	8.39	8.44	10	9.60	9.82	9.81	12
Operating Cost of Revenue	6.32	7.04	10	8.00	8.39	8.44	10	9.60	9.82	9.81	12
Total Operating Expenses	39	38	41	42	42	40	44	45	46	44	47
Selling, General & Admin Expense	7.80	7.71	8.08	8.18	8.33	8.10	9.15	9.96	11	10	9.83
Marketing Expense	27	27	29	29	29	27	31	31	31	30	33
Research & Development Expense	3.66	3.92	4.16	4.35	4.35	3.99	3.87	4.53	4.31	4.24	4.36
Total Other Income / (Expense), net	0.76	1.15	1.38	1.14	1.14	1.06	1.08	0.94	0.85	0.85	0.79
Interest Expense	0.85	0.88	0.89	0.88	0.88	0.88	0.80	0.66	0.67	0.67	0.63
Interest & Investment Income	1.58	2.17	2.23	2.11	2.02	1.94	1.78	1.59	1.52	1.52	1.45
Basic Earnings per Share	($0.30)	($0.25)	($0.26)	($0.27)	($0.22)	($0.16)	($0.10)	($0.15)	($0.14)	($0.11)	($0.04)
Weighted Average Basic Shares Outstanding	37.86M	40.27M	38.43M	40.93M	41.32M	41.72M	41.47M	42.34M	42.79M	43.19M	42.96M
Diluted Earnings per Share	($0.30)	($0.25)	($0.26)	($0.27)	($0.22)	($0.16)	($0.10)	($0.15)	($0.14)	($0.11)	($0.04)
Weighted Average Diluted Shares Outstanding	37.86M	40.27M	38.43M	40.93M	41.32M	41.72M	41.47M	42.34M	42.79M	43.19M	42.96M
Weighted Average Basic & Diluted Shares Outstanding	40.20M	40.50M	41.06M	41.20M	41.69M	41.94M	42.45M	42.61M	43.14M	43.39M	44.17M

This table details how cash moves in and out of SiBone's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-5.49	2.71	-15	43	9.84	-43	13	1.68	7.29
Net Cash From Operating Activities	-18	-15	-32	-31	-40	-42	-19	-12	-0.68
Net Cash From Continuing Operating Activities	-18	-15	-32	-31	-40	-42	-19	-12	-0.68
Net Income / (Loss) Continuing Operations	-23	-17	-38	-44	-57	-61	-43	-31	-19
Consolidated Net Income / (Loss)	-23	-17	-38	-44	-57	-61	-43	-31	-19
Depreciation Expense	1.01	0.72	0.77	1.13	2.09	3.45	5.43	4.38	5.77
Amortization Expense	0.29	0.05	-1.15	0.41	1.58	0.43	-3.80	-5.29	-2.93
Non-Cash Adjustments To Reconcile Net Income	3.83	3.19	7.64	14	19	24	28	30	30
Changes in Operating Assets and Liabilities, net	0.38	-1.03	-0.48	-2.53	-5.76	-7.96	-4.83	-10	-14
Net Cash From Investing Activities	-0.48	-98	13	-63	52	-2.82	-60	13	4.16
Net Cash From Continuing Investing Activities	-0.48	-98	13	-63	52	-2.82	-60	13	4.16
Purchase of Property, Plant & Equipment	-0.48	-0.94	-2.45	-2.56	-6.39	-9.51	-7.80	-10	-8.41
Purchase of Investments	0.00	-97	-144	-179	-102	-120	-189	-205	-193
Sale and/or Maturity of Investments	-	0.00	160	119	160	126	138	229	205
Net Cash From Financing Activities	13	115	3.49	136	-1.71	2.20	91	1.96	3.38
Net Cash From Continuing Financing Activities	13	115	3.49	136	-1.71	2.20	91	1.96	3.38
Repayment of Debt	-32	-	0.00	-47	-42	0.00	-35	-36	0.00
Issuance of Debt	40	-	0.00	45	35	0.00	36	36	0.00
Issuance of Common Equity	0.00	116	2.20	137	2.34	1.82	86	2.15	2.21
Other Financing Activities, net	0.38	1.61	1.49	1.46	2.57	0.38	4.39	-0.15	1.17
Effect of Exchange Rate Changes	-0.35	-	-	0.32	-0.50	-0.43	0.13	-0.48	0.43
Cash Interest Paid	4.51	5.50	4.95	4.28	3.23	2.62	3.26	3.35	2.53

This table details how cash moves in and out of SiBone's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025
Net Change in Cash & Equivalents	88	-57	-20	-1.23	-6.46	4.65	4.72	6.24	-7.04	-7.66	16
Net Cash From Operating Activities	-3.59	-2.07	-2.30	-7.57	-6.33	0.30	1.18	-4.91	0.17	2.34	1.73
Net Cash From Continuing Operating Activities	-3.59	-2.07	-2.30	-7.57	-6.33	0.30	1.18	-4.91	0.17	2.34	1.73
Net Income / (Loss) Continuing Operations	-11	-10	-11	-11	-8.94	-6.58	-4.50	-6.54	-6.15	-4.57	-1.64
Consolidated Net Income / (Loss)	-11	-10	-11	-11	-8.94	-6.58	-4.50	-6.54	-6.15	-4.57	-1.64
Depreciation Expense	1.24	1.53	1.57	1.09	0.99	1.09	1.21	1.28	1.37	1.49	1.64
Amortization Expense	-0.59	-1.13	-1.55	-1.52	-1.42	-1.19	-1.16	-0.89	-0.79	-0.67	-0.58
Non-Cash Adjustments To Reconcile Net Income	6.36	6.81	8.23	7.50	7.35	7.08	7.59	7.44	8.22	7.65	6.41
Changes in Operating Assets and Liabilities, net	0.61	0.73	0.44	-3.74	-4.33	-0.09	-1.97	-6.20	-2.47	-1.57	-4.09
Net Cash From Investing Activities	2.28	-55	-19	6.35	-1.83	3.77	4.34	11	-9.47	-10	13
Net Cash From Continuing Investing Activities	2.28	-55	-19	6.35	-1.83	3.77	4.34	11	-9.47	-10	13
Purchase of Property, Plant & Equipment	-2.71	-1.41	-1.09	-2.08	-3.11	-3.04	-2.27	-2.07	-2.10	-2.96	-1.29
Purchase of Investments	-34	-78	-62	-59	-51	-61	-35	-47	-51	-59	-35
Sale and/or Maturity of Investments	39	25	44	67	52	68	42	60	44	52	49
Net Cash From Financing Activities	89	-0.24	0.84	0.11	1.78	0.16	-0.08	0.10	2.23	0.01	1.03
Net Cash From Continuing Financing Activities	89	-0.24	0.84	0.11	1.78	0.16	-0.08	0.10	2.23	0.01	1.03
Issuance of Common Equity	-	-0.47	0.72	-	-	-	0.68	-	-	-	0.64
Other Financing Activities, net	3.52	0.23	0.12	0.11	0.30	0.16	-0.71	0.10	0.67	0.01	0.39
Effect of Exchange Rate Changes	0.03	-0.14	0.15	-0.11	-0.08	0.42	-0.71	0.42	0.03	0.02	-0.03

This table presents SiBone's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	36	139	117	223	191	158	230	230	239
Total Current Assets	34	136	111	218	176	138	211	208	216
Cash & Equivalents	22	25	10	54	63	21	33	35	42
Short-Term Investments	0.00	97	81	143	84	77	133	115	106
Accounts Receivable	7.42	8.49	12	14	14	21	22	27	30
Inventories, net	2.55	3.34	5.45	5.63	11	17	20	27	34
Prepaid Expenses	1.25	1.99	2.51	2.57	3.14	2.37	3.17	3.20	4.48
Plant, Property, & Equipment, net	1.90	2.15	3.95	4.53	8.99	16	16	20	21
Total Noncurrent Assets	0.31	0.33	1.59	0.37	5.65	4.38	3.03	2.28	1.14
Other Noncurrent Operating Assets	0.31	0.33	0.32	0.37	5.65	4.38	3.03	2.28	1.14
Total Liabilities & Shareholders' Equity	36	139	117	223	191	158	230	230	239
Total Liabilities	47	48	54	54	56	59	61	63	61
Total Current Liabilities	7.54	9.01	19	13	17	21	23	27	25
Accounts Payable	1.81	2.15	2.81	3.27	3.20	6.28	4.59	6.49	4.63
Accrued Expenses	5.72	6.86	12	10	12	14	17	19	20
Other Current Liabilities	-	-	-	-	1.34	1.39	1.42	1.15	0.94
Total Noncurrent Liabilities	39	39	35	40	39	38	38	36	36
Long-Term Debt	39	39	35	39	35	35	36	35	36
Capital Lease Obligations	-	-	-	-	4.17	2.87	1.51	0.88	0.18
Other Noncurrent Operating Liabilities	0.42	0.36	0.36	0.85	0.06	0.03	0.02	0.01	0.00
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-129	90	63	169	134	98	169	167	178
Total Preferred & Common Equity	-129	90	63	169	134	98	169	167	178
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-129	90	63	169	134	98	169	167	178
Common Stock	9.94	247	258	408	430	455	569	598	627
Retained Earnings	-140	-157	-196	-239	-296	-357	-400	-431	-450
Accumulated Other Comprehensive Income / (Loss)	0.40	0.44	0.46	0.52	0.35	0.23	0.34	0.24	0.82

This table presents SiBone's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2022	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	6/30/2022	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025
Total Assets	166	158	149	234	231	224	224	227	227	231	234
Total Current Assets	148	139	128	213	211	204	202	204	204	207	211
Cash & Equivalents	24	26	23	111	53	32	26	30	41	34	26
Short-Term Investments	90	78	63	59	113	126	126	121	103	111	119
Accounts Receivable	15	16	23	20	20	22	25	25	27	24	27
Inventories, net	16	17	18	21	22	21	23	26	30	34	36
Prepaid Expenses	2.33	1.79	2.05	2.14	1.94	2.65	2.78	2.45	2.70	3.29	2.78
Plant, Property, & Equipment, net	13	14	17	18	16	17	19	21	21	22	22
Total Noncurrent Assets	5.00	4.64	4.05	3.71	3.37	2.74	2.40	2.55	2.00	1.77	1.56
Other Noncurrent Operating Assets	5.00	4.64	4.05	3.71	3.37	2.74	2.40	2.55	2.00	1.77	1.56
Total Liabilities & Shareholders' Equity	166	158	149	234	231	224	224	227	227	231	234
Total Liabilities	55	55	55	56	57	58	59	62	60	61	62
Total Current Liabilities	17	19	17	18	19	21	22	25	24	25	26
Accounts Payable	5.14	4.61	5.33	6.16	4.42	7.66	7.18	7.32	7.71	7.50	7.72
Accrued Expenses	10	11	9.90	11	14	12	13	16	15	16	18
Other Current Liabilities	1.34	1.34	1.40	1.40	1.40	1.43	1.38	1.21	1.09	1.11	1.13
Total Noncurrent Liabilities	39	37	38	38	38	37	37	37	36	36	36
Long-Term Debt	35	34	36	36	36	36	36	36	35	36	36
Capital Lease Obligations	3.53	3.18	2.53	2.21	1.87	1.19	0.89	1.14	0.58	0.32	0.17
Other Noncurrent Operating Liabilities	0.04	0.03	0.03	0.02	0.02	0.02	0.01	0.01	0.00	0.00	0.00
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	111	103	94	177	174	166	165	165	167	170	172
Total Preferred & Common Equity	111	103	94	177	174	166	165	165	167	170	172
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	111	103	94	177	174	166	165	165	167	170	172
Common Stock	443	449	462	557	563	577	585	591	605	614	620
Retained Earnings	-332	-346	-368	-379	-389	-411	-420	-427	-438	-444	-449
Accumulated Other Comprehensive Income / (Loss)	0.03	0.16	0.30	0.30	0.36	0.27	0.23	0.58	0.32	0.66	0.77

This table displays calculated financial ratios and metrics derived from SiBone's official financial filings.

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	15.42%	21.53%	9.04%	22.84%	18.03%	30.52%	20.37%	20.19%
EBITDA Growth	0.00%	21.45%	-194.81%	-2.12%	-28.44%	-16.77%	18.71%	20.19%	46.14%
EBIT Growth	0.00%	22.90%	-174.55%	-7.47%	-32.82%	-15.99%	21.27%	24.89%	36.72%
NOPAT Growth	0.00%	31.04%	-200.90%	-7.12%	-33.97%	-15.36%	21.27%	24.89%	36.65%
Net Income Growth	0.00%	24.25%	-120.04%	-13.79%	-29.46%	-8.28%	29.25%	28.67%	38.85%
EPS Growth	0.00%	66.92%	29.55%	3.23%	-14.00%	-4.68%	36.87%	33.63%	41.33%
Operating Cash Flow Growth	0.00%	17.18%	-117.83%	3.05%	-28.93%	-5.37%	55.08%	33.60%	94.57%
Free Cash Flow Firm Growth	0.00%	0.00%	-178.85%	-10.08%	-66.71%	-7.62%	35.92%	-6.52%	24.77%
Invested Capital Growth	0.00%	26.82%	32.33%	35.03%	114.60%	46.93%	4.81%	30.10%	22.91%
Revenue Q/Q Growth	0.00%	0.00%	6.63%	3.28%	3.54%	6.74%	5.23%	6.46%	3.80%
EBITDA Q/Q Growth	0.00%	0.00%	-11.16%	2.11%	-13.27%	4.69%	-4.73%	16.30%	17.06%
EBIT Q/Q Growth	0.00%	0.00%	-11.64%	0.98%	-13.15%	4.84%	-3.12%	16.59%	11.87%
NOPAT Q/Q Growth	0.00%	0.00%	-13.13%	1.57%	-13.29%	4.24%	-2.65%	16.59%	11.95%
Net Income Q/Q Growth	0.00%	0.00%	-10.93%	0.27%	-10.76%	5.11%	0.44%	17.35%	13.11%
EPS Q/Q Growth	0.00%	0.00%	-2,483.33%	6.25%	-11.76%	6.28%	5.04%	17.58%	12.00%
Operating Cash Flow Q/Q Growth	0.00%	-18.64%	-9.39%	3.62%	-13.92%	12.48%	19.31%	21.86%	44.90%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	-0.09%	-25.17%	13.87%	12.50%	-1.83%	1.85%
Invested Capital Q/Q Growth	0.00%	0.00%	38.50%	32.06%	50.26%	5.43%	-8.50%	3.44%	5.42%
Profitability Metrics	-	-	-	-	-	-	-	-	-
Gross Margin	89.35%	91.27%	89.91%	87.87%	88.43%	85.24%	78.78%	79.03%	79.57%
EBITDA Margin	-32.74%	-22.29%	-54.06%	-50.63%	-52.94%	-52.37%	-32.62%	-21.63%	-9.71%
Operating Margin	-36.16%	-21.61%	-53.50%	-52.55%	-57.31%	-56.02%	-33.79%	-21.08%	-11.11%
EBIT Margin	-35.45%	-23.68%	-53.50%	-52.72%	-57.01%	-56.02%	-33.79%	-21.08%	-11.12%
Profit (Net Income) Margin	-48.01%	-31.52%	-57.06%	-59.54%	-62.75%	-57.57%	-31.20%	-18.49%	-9.41%
Tax Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.22%	99.68%	100.24%	100.00%
Interest Burden Percent	135.44%	133.09%	106.66%	112.93%	110.08%	102.54%	92.64%	87.49%	84.58%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-222.19%	-135.11%	-312.97%	-250.45%	-185.64%	-127.15%	-82.14%	-52.39%	-26.34%
ROIC Less NNEP Spread (ROIC-NNEP)	-289.04%	-108.00%	-293.71%	-234.60%	-170.23%	-103.77%	-70.97%	-47.24%	-23.44%
Return on Net Nonoperating Assets (RNNOA)	434.92%	91.13%	262.84%	212.84%	148.40%	74.51%	49.76%	34.01%	15.36%
Return on Equity (ROE)	212.73%	-43.98%	-50.13%	-37.61%	-37.25%	-52.64%	-32.38%	-18.38%	-10.97%
Cash Return on Invested Capital (CROIC)	0.00%	-158.76%	-340.80%	-280.25%	-258.50%	-165.16%	-86.84%	-78.56%	-46.89%
Operating Return on Assets (OROA)	-47.47%	-15.04%	-28.18%	-22.75%	-24.85%	-34.25%	-24.19%	-15.30%	-9.53%
Return on Assets (ROA)	-64.29%	-20.02%	-30.06%	-25.69%	-27.35%	-35.20%	-22.34%	-13.42%	-8.06%
Return on Common Equity (ROCE)	2,541.37%	21.72%	-50.13%	-37.61%	-37.25%	-52.64%	-32.38%	-18.38%	-10.97%
Return on Equity Simple (ROE_SIMPLE)	17.81%	-19.35%	-60.95%	-25.80%	-42.09%	-62.31%	-25.59%	-18.51%	0.00%
Net Operating Profit after Tax (NOPAT)	-12	-8.38	-25	-27	-36	-42	-33	-25	-16
NOPAT Margin	-25.31%	-15.12%	-37.45%	-36.79%	-40.12%	-39.21%	-23.65%	-14.76%	-7.78%
Net Nonoperating Expense Percent (NNEP)	66.85%	-27.11%	-19.26%	-15.84%	-15.41%	-23.38%	-11.17%	-5.15%	-2.90%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-30.60%	-15.87%	-12.14%	-7.33%
Cost of Revenue to Revenue	10.65%	8.73%	10.09%	12.13%	11.57%	14.76%	21.22%	20.97%	20.43%
SG&A Expenses to Revenue	27.22%	22.82%	31.18%	26.98%	27.81%	27.22%	22.37%	20.19%	20.18%
R&D to Revenue	11.49%	9.71%	10.82%	12.89%	13.80%	12.81%	10.82%	9.91%	8.68%
Operating Expenses to Revenue	125.50%	112.88%	143.41%	140.42%	145.75%	141.26%	112.58%	100.11%	90.69%
Earnings before Interest and Taxes (EBIT)	-17	-13	-36	-39	-51	-60	-47	-35	-22
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-16	-12	-36	-37	-48	-56	-45	-36	-20
Valuation Ratios	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	5.64	8.53	5.71	5.53	4.77	5.02	3.52	4.82
Price to Tangible Book Value (P/TBV)	0.00	5.64	8.53	5.71	5.53	4.77	5.02	3.52	4.82
Price to Revenue (P/Rev)	2.25	9.18	7.99	13.18	8.25	4.41	6.12	3.52	4.26
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	44.43	61.33	52.74	65.45	23.93	10.50	17.63	8.91	11.36
Enterprise Value to Revenue (EV/Rev)	5.06	7.68	7.19	11.05	7.05	3.85	5.20	2.84	3.70
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-
Debt to Equity	-3.57	0.43	0.62	0.23	0.29	0.39	0.22	0.22	0.20
Long-Term Debt to Equity	-3.57	0.43	0.55	0.23	0.29	0.39	0.22	0.22	0.20
Financial Leverage	-1.50	-0.84	-0.89	-0.91	-0.87	-0.72	-0.70	-0.72	-0.66
Leverage Ratio	-3.31	2.20	1.67	1.46	1.36	1.50	1.45	1.37	1.36
Compound Leverage Factor	-4.48	2.92	1.78	1.65	1.50	1.53	1.34	1.20	1.15
Debt to Total Capital	138.85%	30.17%	38.37%	18.89%	22.55%	27.90%	18.16%	17.87%	16.76%
Short-Term Debt to Total Capital	0.00%	0.00%	4.26%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	138.85%	30.17%	34.10%	18.89%	22.55%	27.90%	18.16%	17.87%	16.76%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	425.30%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	-464.15%	69.83%	61.63%	81.11%	77.45%	72.10%	81.84%	82.13%	83.24%
Debt to EBITDA	-2.46	-3.16	-1.08	-1.06	-0.82	-0.68	-0.83	-1.00	-1.83
Net Debt to EBITDA	-1.04	6.75	1.48	4.22	2.26	1.06	2.84	3.15	5.74
Long-Term Debt to EBITDA	-2.46	-3.16	-0.96	-1.06	-0.82	-0.68	-0.83	-1.00	-1.83
Debt to NOPAT	-3.19	-4.65	-1.56	-1.46	-1.08	-0.91	-1.14	-1.47	-2.29
Net Debt to NOPAT	-1.34	9.94	2.14	5.81	2.98	1.42	3.91	4.61	7.17
Long-Term Debt to NOPAT	-3.19	-4.65	-1.38	-1.46	-1.08	-0.91	-1.14	-1.47	-2.29
Altman Z-Score	-3.42	5.91	4.14	10.15	6.37	1.89	6.83	4.10	7.26
Noncontrolling Interest Sharing Ratio	-1,094.63%	149.38%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-
Current Ratio	4.46	15.11	5.94	16.20	10.41	6.50	9.01	7.66	8.55
Quick Ratio	3.96	14.51	5.51	15.59	9.55	5.57	8.01	6.54	7.03
Cash Flow Metrics	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-9.84	-27	-30	-50	-54	-35	-37	-28
Operating Cash Flow to CapEx	-3,667.36%	-1,541.30%	-1,293.54%	-1,197.27%	-618.77%	-438.15%	-239.94%	-118.37%	-8.02%
Free Cash Flow to Firm to Interest Expense	0.00	-1.93	-5.55	-4.95	-9.39	-19.23	-10.03	-10.75	-10.59
Operating Cash Flow to Interest Expense	-2.83	-2.84	-6.39	-5.03	-7.37	-14.78	-5.41	-3.61	-0.26
Operating Cash Flow Less CapEx to Interest Expense	-2.90	-3.03	-6.88	-5.45	-8.56	-18.15	-7.66	-6.66	-3.46
Efficiency Ratios	-	-	-	-	-	-	-	-	-
Asset Turnover	1.34	0.64	0.53	0.43	0.44	0.61	0.72	0.73	0.86
Accounts Receivable Turnover	6.47	6.97	6.66	5.79	6.47	6.09	6.52	6.77	7.00
Inventory Turnover	2.00	1.64	1.54	1.61	1.22	1.09	1.57	1.48	1.35
Fixed Asset Turnover	25.31	27.35	22.04	17.31	13.34	8.67	8.80	9.19	9.64
Accounts Payable Turnover	2.82	2.44	2.74	2.93	3.22	3.31	5.42	6.33	7.38
Days Sales Outstanding (DSO)	56.41	52.40	54.79	62.99	56.39	59.89	56.01	53.94	52.11
Days Inventory Outstanding (DIO)	182.29	222.64	236.39	227.25	299.81	334.44	232.45	246.35	271.09
Days Payable Outstanding (DPO)	129.52	149.53	133.23	124.69	113.21	110.13	67.31	57.66	49.44
Cash Conversion Cycle (CCC)	109.18	125.51	157.95	165.56	242.99	284.20	221.16	242.64	273.77
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-
Invested Capital	5.47	6.93	9.17	12	27	39	41	53	65
Invested Capital Turnover	8.78	8.93	8.36	6.81	4.63	3.24	3.47	3.55	3.39
Increase / (Decrease) in Invested Capital	0.00	1.47	2.24	3.21	14	12	1.88	12	12
Enterprise Value (EV)	243	425	484	811	636	410	722	474	744
Market Capitalization	108	508	538	968	744	469	850	588	856
Book Value per Share	($37.32)	$3.71	$2.52	$5.23	$4.01	$2.85	$4.18	$3.98	$4.09
Tangible Book Value per Share	($37.32)	$3.71	$2.52	$5.23	$4.01	$2.85	$4.18	$3.98	$4.09
Total Capital	28	129	102	209	174	136	207	203	213
Total Debt	39	39	39	39	39	38	38	36	36
Total Long-Term Debt	39	39	35	39	39	38	38	36	36
Net Debt	16	-83	-54	-157	-108	-59	-128	-114	-112
Capital Expenditures (CapEx)	0.48	0.94	2.45	2.56	6.39	9.51	7.80	10	8.41
Debt-free, Cash-free Net Working Capital (DFCFNWC)	3.68	4.81	5.27	8.34	12	19	22	31	43
Debt-free Net Working Capital (DFNWC)	26	127	97	205	159	116	188	181	191
Net Working Capital (NWC)	26	127	93	205	159	116	188	181	191
Net Nonoperating Expense (NNE)	11	9.08	13	17	20	20	10	6.24	3.27
Net Nonoperating Obligations (NNO)	16	-83	-54	-157	-108	-59	-128	-114	-112
Total Depreciation and Amortization (D&A)	1.30	0.77	-0.38	1.54	3.67	3.88	1.63	-0.91	2.84
Debt-free, Cash-free Net Working Capital to Revenue	7.68%	8.69%	7.82%	11.36%	13.31%	17.99%	15.78%	18.31%	21.41%
Debt-free Net Working Capital to Revenue	54.38%	229.39%	144.20%	279.03%	176.34%	109.42%	135.32%	108.06%	94.98%
Net Working Capital to Revenue	54.38%	229.39%	137.72%	279.03%	176.34%	109.42%	135.32%	108.06%	94.98%
Earnings Adjustments	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($6.65)	($2.20)	($1.55)	($1.50)	($1.71)	($1.79)	($1.13)	($0.75)	($0.44)
Adjusted Weighted Average Basic Shares Outstanding	3.47M	24.46M	28.38M	32.73M	33.15M	34.20M	38.43M	41.47M	42.96M
Adjusted Diluted Earnings per Share	($6.65)	($2.20)	($1.55)	($1.50)	($1.71)	($1.79)	($1.13)	($0.75)	($0.44)
Adjusted Weighted Average Diluted Shares Outstanding	3.47M	24.46M	28.38M	32.73M	33.15M	34.20M	38.43M	41.47M	42.96M
Adjusted Basic & Diluted Earnings per Share	($6.65)	($2.20)	($1.55)	($1.50)	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	3.47M	7.95M	24.71M	29.06M	33.84M	34.99M	41.06M	42.45M	44.17M
Normalized Net Operating Profit after Tax (NOPAT)	-12	-8.38	-25	-27	-36	-42	-33	-25	-16
Normalized NOPAT Margin	-25.31%	-15.12%	-37.45%	-36.79%	-40.12%	-39.21%	-23.65%	-14.76%	-7.78%
Pre Tax Income Margin	-48.01%	-31.52%	-57.06%	-59.54%	-62.75%	-57.44%	-31.30%	-18.45%	-9.41%
Debt Service Ratios	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-2.74	-2.57	-7.28	-6.34	-9.58	-21.15	-13.56	-10.25	-8.50
NOPAT to Interest Expense	-1.96	-1.64	-5.09	-4.43	-6.74	-14.80	-9.49	-7.17	-5.95
EBIT Less CapEx to Interest Expense	-2.82	-2.75	-7.77	-6.76	-10.77	-24.52	-15.81	-13.30	-11.71
NOPAT Less CapEx to Interest Expense	-2.03	-1.82	-5.59	-4.84	-7.93	-18.17	-11.74	-10.22	-9.15
Payout Ratios	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-5.61%	-11.29%	-0.43%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from SiBone's official financial filings.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	30.17%	28.68%	21.61%	15.77%	20.01%	18.60%	26.10%	24.88%	21.67%	20.61%	14.99%
EBITDA Growth	33.23%	13.75%	-17.29%	-17.80%	7.06%	29.01%	56.41%	43.65%	38.73%	40.94%	74.09%
EBIT Growth	33.78%	17.72%	-10.73%	-8.17%	15.61%	32.52%	56.07%	38.43%	30.45%	29.42%	55.09%
NOPAT Growth	33.10%	17.67%	-10.73%	-6.64%	15.76%	31.66%	56.07%	37.89%	30.50%	29.48%	55.17%
Net Income Growth	39.47%	29.21%	1.72%	1.99%	20.23%	34.39%	59.07%	40.00%	31.18%	30.56%	63.43%
EPS Growth	44.44%	39.02%	18.75%	15.63%	26.67%	36.00%	61.54%	44.44%	36.36%	31.25%	60.00%
Operating Cash Flow Growth	75.81%	68.24%	66.10%	29.59%	-76.43%	114.57%	151.28%	35.13%	102.73%	673.18%	46.69%
Free Cash Flow Firm Growth	35.67%	46.25%	47.83%	70.57%	42.99%	22.03%	-52.06%	-173.84%	-37.39%	-18.86%	13.87%
Invested Capital Growth	31.82%	20.76%	4.81%	-3.10%	8.82%	15.09%	30.10%	30.88%	20.67%	20.60%	22.91%
Revenue Q/Q Growth	1.83%	2.13%	14.24%	-2.55%	5.55%	0.93%	21.47%	-3.49%	2.83%	0.05%	15.81%
EBITDA Q/Q Growth	-5.88%	3.44%	-14.46%	-2.19%	16.47%	26.26%	29.71%	-30.14%	9.17%	28.98%	69.20%
EBIT Q/Q Growth	-6.41%	5.24%	-10.56%	1.50%	16.99%	24.23%	28.02%	-36.00%	6.24%	23.17%	54.24%
NOPAT Q/Q Growth	-5.93%	6.64%	-11.97%	3.70%	16.32%	24.26%	28.02%	-36.15%	6.36%	23.14%	54.24%
Net Income Q/Q Growth	-0.73%	10.57%	-9.59%	0.72%	18.02%	26.45%	31.64%	-45.54%	5.96%	25.78%	63.99%
EPS Q/Q Growth	6.25%	16.67%	-4.00%	-3.85%	18.52%	27.27%	37.50%	-50.00%	6.67%	21.43%	63.64%
Operating Cash Flow Q/Q Growth	66.61%	42.26%	-10.81%	-229.60%	16.34%	104.77%	290.07%	-516.89%	103.52%	1,249.71%	-26.00%
Free Cash Flow Firm Q/Q Growth	17.78%	20.55%	31.44%	34.27%	-59.24%	-8.67%	-33.70%	-18.37%	20.11%	5.99%	3.12%
Invested Capital Q/Q Growth	-0.62%	-3.11%	-8.50%	9.97%	11.61%	2.47%	3.44%	10.63%	2.91%	2.41%	5.42%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	81.03%	79.30%	73.80%	78.87%	79.00%	79.09%	79.13%	79.71%	79.80%	79.84%	79.03%
EBITDA Margin	-33.91%	-32.06%	-32.12%	-33.18%	-26.26%	-19.19%	-11.10%	-14.97%	-13.23%	-9.39%	-2.50%
Operating Margin	-35.92%	-32.84%	-32.18%	-31.80%	-25.21%	-18.92%	-11.21%	-15.82%	-14.40%	-11.06%	-4.37%
EBIT Margin	-35.84%	-33.26%	-32.18%	-32.05%	-25.20%	-18.92%	-11.21%	-15.80%	-14.41%	-11.06%	-4.37%
Profit (Net Income) Margin	-33.65%	-29.46%	-28.26%	-28.80%	-22.36%	-16.30%	-9.17%	-13.83%	-12.65%	-9.38%	-2.92%
Tax Burden Percent	100.00%	100.00%	98.73%	100.00%	100.00%	99.91%	101.79%	100.00%	100.00%	100.62%	98.33%
Interest Burden Percent	93.87%	88.60%	88.95%	89.85%	88.73%	86.22%	80.38%	87.55%	87.81%	84.30%	67.88%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-77.05%	-74.19%	-78.23%	-70.12%	-55.18%	-43.23%	-27.86%	-37.63%	-33.69%	-26.40%	-10.36%
ROIC Less NNEP Spread (ROIC-NNEP)	-74.31%	-71.93%	-75.86%	-67.17%	-53.65%	-42.22%	-27.33%	-36.49%	-32.58%	-25.69%	-10.43%
Return on Net Nonoperating Assets (RNNOA)	53.38%	50.65%	53.19%	43.49%	38.53%	30.22%	19.67%	25.09%	21.80%	17.03%	6.84%
Return on Equity (ROE)	-23.67%	-23.54%	-25.04%	-26.62%	-16.65%	-13.01%	-8.19%	-12.54%	-11.89%	-9.37%	-3.52%
Cash Return on Invested Capital (CROIC)	-110.42%	-97.08%	-86.84%	-69.83%	-74.95%	-75.52%	-78.56%	-68.08%	-53.60%	-49.94%	-46.89%
Operating Return on Assets (OROA)	-22.30%	-22.56%	-23.04%	-24.77%	-16.60%	-12.98%	-8.13%	-12.37%	-11.74%	-9.29%	-3.75%
Return on Assets (ROA)	-20.93%	-19.99%	-20.24%	-22.25%	-14.73%	-11.18%	-6.66%	-10.83%	-10.31%	-7.88%	-2.50%
Return on Common Equity (ROCE)	-23.67%	-23.54%	-25.04%	-26.62%	-16.65%	-13.01%	-8.19%	-12.54%	-11.89%	-9.37%	-3.52%
Return on Equity Simple (ROE_SIMPLE)	-26.87%	-25.07%	0.00%	-26.05%	-24.80%	-22.67%	0.00%	-15.87%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-8.37	-7.82	-8.75	-8.43	-7.05	-5.34	-3.85	-5.24	-4.90	-3.77	-1.72
NOPAT Margin	-25.14%	-22.99%	-22.53%	-22.26%	-17.65%	-13.25%	-7.85%	-11.07%	-10.08%	-7.74%	-3.06%
Net Nonoperating Expense Percent (NNEP)	-2.74%	-2.26%	-2.38%	-2.94%	-1.53%	-1.02%	-0.54%	-1.14%	-1.11%	-0.71%	0.07%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-4.23%	-	-	-	-1.89%	-2.58%	-2.38%	-1.81%	-0.81%
Cost of Revenue to Revenue	18.97%	20.70%	26.21%	21.13%	21.00%	20.91%	20.87%	20.29%	20.20%	20.16%	20.97%
SG&A Expenses to Revenue	23.43%	22.67%	20.80%	21.59%	20.85%	20.07%	18.68%	21.06%	22.05%	20.62%	17.44%
R&D to Revenue	10.98%	11.52%	10.71%	11.47%	10.89%	9.90%	7.90%	9.59%	8.86%	8.72%	7.74%
Operating Expenses to Revenue	116.95%	112.14%	105.98%	110.67%	104.22%	98.01%	90.35%	95.53%	94.20%	90.90%	83.40%
Earnings before Interest and Taxes (EBIT)	-12	-11	-13	-12	-10	-7.63	-5.49	-7.47	-7.01	-5.38	-2.46
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-11	-11	-12	-13	-10	-7.74	-5.44	-7.08	-6.43	-4.57	-1.41
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	5.35	4.92	5.02	4.01	3.23	3.53	3.52	3.56	4.71	3.69	4.82
Price to Tangible Book Value (P/TBV)	5.35	4.92	5.02	4.01	3.23	3.53	3.52	3.56	4.71	3.69	4.82
Price to Revenue (P/Rev)	7.63	6.47	6.12	4.60	3.54	3.71	3.52	3.37	4.33	3.28	4.26
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	17.72	16.21	17.63	12.05	8.33	9.12	8.91	8.27	11.42	8.46	11.36
Enterprise Value to Revenue (EV/Rev)	6.58	5.49	5.20	3.77	2.78	2.99	2.84	2.76	3.74	2.71	3.70
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.22	0.22	0.22	0.23	0.22	0.23	0.22	0.22	0.21	0.21	0.20
Long-Term Debt to Equity	0.22	0.22	0.22	0.23	0.22	0.23	0.22	0.22	0.21	0.21	0.20
Financial Leverage	-0.72	-0.70	-0.70	-0.65	-0.72	-0.72	-0.72	-0.69	-0.67	-0.66	-0.66
Leverage Ratio	1.39	1.41	1.45	1.44	1.34	1.35	1.37	1.36	1.36	1.37	1.36
Compound Leverage Factor	1.30	1.25	1.29	1.29	1.19	1.17	1.10	1.19	1.19	1.15	0.92
Debt to Total Capital	17.71%	17.91%	18.16%	18.39%	18.36%	18.45%	17.87%	17.74%	17.38%	17.18%	16.76%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	17.71%	17.91%	18.16%	18.39%	18.36%	18.45%	17.87%	17.74%	17.38%	17.18%	16.76%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	82.29%	82.09%	81.84%	81.61%	81.64%	81.55%	82.13%	82.26%	82.62%	82.82%	83.24%
Debt to EBITDA	-0.85	-0.88	-0.83	-0.79	-0.80	-0.86	-1.00	-1.17	-1.34	-1.52	-1.83
Net Debt to EBITDA	2.92	2.98	2.84	2.56	2.47	2.63	3.15	3.52	4.11	4.68	5.74
Long-Term Debt to EBITDA	-0.85	-0.88	-0.83	-0.79	-0.80	-0.86	-1.00	-1.17	-1.34	-1.52	-1.83
Debt to NOPAT	-1.13	-1.18	-1.14	-1.12	-1.16	-1.26	-1.47	-1.68	-1.85	-2.01	-2.29
Net Debt to NOPAT	3.90	4.03	3.91	3.61	3.57	3.84	4.61	5.04	5.68	6.20	7.17
Long-Term Debt to NOPAT	-1.13	-1.18	-1.14	-1.12	-1.16	-1.26	-1.47	-1.68	-1.85	-2.01	-2.29
Altman Z-Score	9.18	7.99	7.32	5.71	4.27	4.53	4.52	4.88	6.90	5.14	7.54
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	11.68	10.89	9.01	9.76	9.17	8.25	7.66	8.53	8.38	7.97	8.55
Quick Ratio	10.43	9.64	8.01	8.63	7.99	7.12	6.54	7.14	6.87	6.52	7.03
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-20	-16	-11	-6.99	-11	-12	-16	-19	-15	-14	-14
Operating Cash Flow to CapEx	-132.28%	-146.71%	-210.16%	-363.64%	-203.47%	9.95%	51.99%	-237.02%	8.24%	79.02%	134.16%
Free Cash Flow to Firm to Interest Expense	-22.96	-17.54	-11.95	-7.93	-12.65	-13.68	-20.34	-28.91	-22.95	-21.45	-22.10
Operating Cash Flow to Interest Expense	-4.22	-2.35	-2.58	-8.59	-7.20	0.34	1.48	-7.42	0.26	3.49	2.74
Operating Cash Flow Less CapEx to Interest Expense	-7.42	-3.94	-3.81	-10.96	-10.74	-3.09	-1.37	-10.55	-2.89	-0.93	0.70
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.62	0.68	0.72	0.77	0.66	0.69	0.73	0.78	0.81	0.84	0.86
Accounts Receivable Turnover	7.00	7.24	6.52	6.44	6.67	7.00	6.77	7.24	7.54	7.53	7.00
Inventory Turnover	1.16	1.24	1.57	1.62	1.54	1.46	1.48	1.43	1.33	1.29	1.35
Fixed Asset Turnover	8.19	8.53	8.80	8.48	8.22	8.43	9.19	9.19	9.08	9.07	9.64
Accounts Payable Turnover	3.81	5.40	5.42	4.86	5.04	5.97	6.33	4.77	5.19	5.25	7.38
Days Sales Outstanding (DSO)	52.14	50.39	56.01	56.64	54.76	52.18	53.94	50.44	48.43	48.50	52.11
Days Inventory Outstanding (DIO)	314.35	293.44	232.45	224.71	237.66	249.41	246.35	256.09	275.47	283.30	271.09
Days Payable Outstanding (DPO)	95.91	67.64	67.31	75.17	72.40	61.18	57.66	76.52	70.33	69.58	49.44
Cash Conversion Cycle (CCC)	270.58	276.19	221.16	206.18	220.02	240.41	242.64	230.02	253.57	262.22	273.77
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	46	45	41	45	50	51	53	59	61	62	65
Invested Capital Turnover	3.06	3.23	3.47	3.15	3.13	3.26	3.55	3.40	3.34	3.41	3.39
Increase / (Decrease) in Invested Capital	11	7.69	1.88	-1.44	4.07	6.75	12	14	10	11	12
Enterprise Value (EV)	818	725	722	542	418	469	474	487	692	525	744
Market Capitalization	949	854	850	663	533	583	588	596	802	635	856
Book Value per Share	$5.04	$4.32	$4.18	$4.04	$4.00	$3.96	$3.98	$3.94	$4.00	$3.99	$4.09
Tangible Book Value per Share	$5.04	$4.32	$4.18	$4.04	$4.00	$3.96	$3.98	$3.94	$4.00	$3.99	$4.09
Total Capital	216	211	207	203	202	202	203	203	206	208	213
Total Debt	38	38	38	37	37	37	36	36	36	36	36
Total Long-Term Debt	38	38	38	37	37	37	36	36	36	36	36
Net Debt	-131	-129	-128	-121	-114	-113	-114	-108	-110	-110	-112
Capital Expenditures (CapEx)	2.71	1.41	1.09	2.08	3.11	3.04	2.27	2.07	2.10	2.96	1.29
Debt-free, Cash-free Net Working Capital (DFCFNWC)	25	25	22	25	29	28	31	36	37	39	43
Debt-free Net Working Capital (DFNWC)	194	192	188	183	180	179	181	180	183	184	191
Net Working Capital (NWC)	194	192	188	183	180	179	181	180	183	184	191
Net Nonoperating Expense (NNE)	2.83	2.20	2.23	2.47	1.88	1.23	0.65	1.31	1.25	0.80	-0.08
Net Nonoperating Obligations (NNO)	-131	-129	-128	-121	-114	-113	-114	-108	-110	-110	-112
Total Depreciation and Amortization (D&A)	0.64	0.41	0.02	-0.43	-0.42	-0.11	0.05	0.39	0.57	0.82	1.06
Debt-free, Cash-free Net Working Capital to Revenue	20.02%	18.86%	15.78%	17.32%	19.07%	17.96%	18.31%	20.29%	20.06%	19.94%	21.41%
Debt-free Net Working Capital to Revenue	156.22%	145.21%	135.32%	126.88%	119.62%	114.00%	108.06%	102.07%	98.62%	95.23%	94.98%
Net Working Capital to Revenue	156.22%	145.21%	135.32%	126.88%	119.62%	114.00%	108.06%	102.07%	98.62%	95.23%	94.98%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.30)	($0.25)	($0.26)	($0.27)	($0.22)	($0.16)	($0.10)	($0.15)	($0.14)	($0.11)	($0.04)
Adjusted Weighted Average Basic Shares Outstanding	37.86M	40.27M	38.43M	40.93M	41.32M	41.72M	41.47M	42.34M	42.79M	43.19M	42.96M
Adjusted Diluted Earnings per Share	($0.30)	($0.25)	($0.26)	($0.27)	($0.22)	($0.16)	($0.10)	($0.15)	($0.14)	($0.11)	($0.04)
Adjusted Weighted Average Diluted Shares Outstanding	37.86M	40.27M	38.43M	40.93M	41.32M	41.72M	41.47M	42.34M	42.79M	43.19M	42.96M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	40.20M	40.50M	41.06M	41.20M	41.69M	41.94M	42.45M	42.61M	43.14M	43.39M	44.17M
Normalized Net Operating Profit after Tax (NOPAT)	-8.37	-7.82	-8.75	-8.43	-7.05	-5.34	-3.85	-5.24	-4.90	-3.77	-1.72
Normalized NOPAT Margin	-25.14%	-22.99%	-22.53%	-22.26%	-17.65%	-13.25%	-7.85%	-11.07%	-10.08%	-7.74%	-3.06%
Pre Tax Income Margin	-33.65%	-29.46%	-28.63%	-28.80%	-22.36%	-16.31%	-9.01%	-13.83%	-12.65%	-9.33%	-2.97%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-14.04	-12.80	-14.05	-13.78	-11.45	-8.63	-6.91	-11.29	-10.52	-8.03	-3.91
NOPAT to Interest Expense	-9.85	-8.84	-9.84	-9.57	-8.02	-6.04	-4.84	-7.91	-7.36	-5.62	-2.74
EBIT Less CapEx to Interest Expense	-17.24	-14.39	-15.28	-16.14	-14.99	-12.07	-9.76	-14.42	-13.67	-12.44	-5.95
NOPAT Less CapEx to Interest Expense	-13.04	-10.44	-11.06	-11.93	-11.55	-9.48	-7.69	-11.04	-10.51	-10.03	-4.78
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Key Financial Trends

Si-BONE, Inc. (SIBN) continues to post growing revenue and solid gross margins, while burning a modest GAAP net loss. Over the last four years, the company has shown improving operating cash flow in some quarters, helped by sizable investment maturities and a strong liquidity position. Below is a concise, investor-focused view of trends from the last four years of quarterly statements.

Q4 2025 revenue rose to about $56.3 million, up from $49.0 million in Q4 2024 (roughly +15% year over year), signaling improving top-line demand.
Gross margin remained robust around 78%–80% across 2025, indicating stable product profitability on a revenue base that has grown in 2025.
Q4 2025 delivered positive cash flow from operating activities (about $1.73 million), suggesting improved cash generation from core operations despite GAAP losses.
Multiple quarters in 2024–2025 generated sizable cash inflows from sale/maturity of investments (e.g., roughly $60.0M in Q2 2025, $52.0M in Q3 2025, and about $49.0M in Q4 2025), providing substantial liquidity to fund operations and investment activity.
Liquidity in mid-2025 was strong: cash and short-term investments totaled roughly $145 million, compared with current liabilities around $24–26 million, creating a healthy cushion for near-term obligations.
Total common equity remained sizeable (approximately $170–172 million in mid-2025), supporting financing flexibility without relying heavily on debt.

Net income remains negative in all periods analyzed (e.g., Q4 2025 net income -$1.6 million; Q3 2025 -$4.6 million; Q2 2025 -$6.2 million; Q1 2025 -$6.5 million), reflecting ongoing GAAP losses despite revenue growth.
Operating expenses are high, with substantial marketing and SG&A spending (for example, Q4 2025 marketing expense around $32.8 million and total operating expenses near $46.99 million), contributing to the ongoing operating loss.
Long-term debt is moderate (about $35–36 million), with total liabilities around $60 million in mid-2025, suggesting leverage is manageable but remains an exposure to monitor as losses persist.
Non-cash adjustments to reconcile net income to cash flow are sizable and help cash flow, but they are non-cash items and may not reflect ongoing cash generation (e.g., meaningful positive "non-cash adjustments" in several quarters).

Investing cash outflows were notable in several quarters (e.g., Q4 2025 net cash from continuing investing activities around -$13.03 million; Q2 2025 around -$9.47 million; Q3 2025 around -$10.03 million), indicating ongoing capital deployment that pressures near-term liquidity if investment inflows slow.
Seasonality and scaling in quarterly revenue create variability in quarterly earnings and free cash flow, complicating near-term earnings visibility and requiring close attention to investment cycles and cost controls.

05/14/26 06:17 PM ETAI Generated. May Contain Errors.

SiBone Financials - Frequently Asked Questions

According to the most recent income statement we have on file, SiBone's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

SiBone's net income appears to be on an upward trend, with a most recent value of -$18.90 million in 2025, falling from -$23.04 million in 2017. The previous period was -$30.91 million in 2024. See where experts think SiBone is headed by visiting SiBone's forecast page.

SiBone's total operating income in 2025 was -$22.33 million, based on the following breakdown:

Total Gross Profit: $159.88 million
Total Operating Expenses: $182.21 million

Over the last 8 years, SiBone's total revenue changed from $47.98 million in 2017 to $200.93 million in 2025, a change of 318.7%.

SiBone's total liabilities were at $61.02 million at the end of 2025, a 3.9% decrease from 2024, and a 30.8% increase since 2017.

In the past 8 years, SiBone's cash and equivalents has ranged from $10.44 million in 2019 to $63.42 million in 2021, and is currently $42.24 million as of their latest financial filing in 2025.

Over the last 8 years, SiBone's book value per share changed from -37.32 in 2017 to 4.09 in 2025, a change of -111.0%.

Related Companies

Financial statements for NASDAQ:SIBN last updated on 2/27/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SiBone (SIBN) Financials

Financials Breakdown Chart

Key Financial Trends

SiBone Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

SiBone (SIBN) Financials

Annual Income Statements for SiBone

Quarterly Income Statements for SiBone

Annual Cash Flow Statements for SiBone

Quarterly Cash Flow Statements for SiBone

Annual Balance Sheets for SiBone

Quarterly Balance Sheets for SiBone

Annual Metrics And Ratios for SiBone

Quarterly Metrics And Ratios for SiBone

Financials Breakdown Chart

Key Financial Trends

SiBone Financials - Frequently Asked Questions

When does SiBone's financial year end?

How has SiBone's net income changed over the last 8 years?

What is SiBone's operating income?

How has SiBone's revenue changed over the last 8 years?

How much debt does SiBone have?

How much cash does SiBone have?

How has SiBone's book value per share changed over the last 8 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools